StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BofA Securities on Medtronic, Inc. (MDT): 'one of few accelerating growth companies in medtech'
March 23, 2026 8:44 AM
BofA Securities analyst Travis Steed reiterated a Buy rating and $110.00 price target on Medtronic, Inc. (NYSE: MDT)The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
